Bionovo (BNVI) Published Phase 1B of Bezielle; Safe and Well Tolerated in Metastatic Breast Cancer Patients
Tweet Send to a Friend
Bionovo, Inc. (NASDAQ: BNVI) announced today the publication of their results from its phase 1B clinical trial of Bezielle (BZL101) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
